MedTrace Logo

Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts

NCT01943630 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-11-01

No results posted yet for this study

Summary

The purpose of this double blind study is to determine whether topical 15% AS101 gel is effective and safe as compared to vehicle in the treatment of external genital warts in women.

Conditions

  • External Genital Warts

Interventions

DRUG

15% AS101 gel

Administration of Topical 15% AS101 once a day (overnight)

DRUG

Vehicle

Administration of Vehicle once a day (overnight)

Sponsors & Collaborators

  • BioMAS Ltd

    lead INDUSTRY

Principal Investigators

  • Shabtai Romano, MD · Ha'Emek Medical center, Department of Gynecology & obstetrics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01943630 on ClinicalTrials.gov